Recce scores $6.75M R&D rebate
Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KNB | Culpeo reports"wide" copper hits at El Quillay North, Chile | 23/10/24 | 0 | 1 | |||
|
See All Discussions